Day: July 20, 2023

ROVI has renewed its ‘Excellent’ rating in the Profarma 2021-2022 Programme for Promoting Competitiveness in the pharmaceutical industry, awarded by the Ministry of Industry, Trade and Tourism.

This programme classifies and rates companies in a series of groups and categories (Excellent, Very Good, Good and Acceptable) according to their excellence in different industrial, economic and research, development and innovation aspects.

The aim is to favour the competitiveness of the sector by boosting activities that provide greater added value, such as investment in new plants and new production technologies, promoting R&D&I.

ROVI receives the award for “Best Shareholder Service by a Listed Company” at Rankia’s 20th anniversary. The event was held at the Círculo de Bellas Artes in Madrid and recognised the most outstanding entities and personalities in the financial world.

With this award, ROVI ratifies its commitment to assertive, direct and transparent communication with its shareholders. The award was collected by Marta Campos Martínez and Beatriz de Zavala, head and member of the Investor Relations department, who congratulated the other winning companies and the Rankia management team for their 20 years working for financial communication.